EUVIMEDEUVIMED entdecken
Open Access

Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma

Xiaozhen Zhang iD, Mengyi Lao iD, Kang Sun, Hanshen Yang iD, Lihong He iD, Xinyuan Liu, Linyue Liu, Sirui Zhang, Chengxiang Guo, Sicheng Wang, Jiatao Shi, Xiaoyu Zhang iD und 4 weitere

Science Advances · 23.05.2025 · 11 (21)

DOI: 10.1126/sciadv.adv0558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 23.05.2025. Verfasst von Xiaozhen Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Tumor-Associated Macrophages, Immunotherapy. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated metabolism of immune cells in the tumor microenvironment leads to immune evasion and tumor progression. As a major cell component in the tumor, the metabolic reprogramming of tumor-associated macrophages (TAMs) creates an immunosuppressive microenvironment in hepatocellular carcinoma (HCC). Our study found that sphingolipid (particularly, sphingosine-1-phosphate or S1P) levels are a clinical indicator for prognosis and immunotherapy response in patients with HCC. S1P primarily derived from TAMs, where NIMA-related kinase 2 (NEK2) plays a key role in controlling the activity of serine palmitoyl-CoA transferase, a rate-limiting enzyme in S1P biosynthesis. The S1P produced by NEK2 hi TAMs promotes hepatic tumor progression and confers immunotherapy resistance. Targeting S1P synthesis with a NEK2 inhibitor or S1P antagonist disrupted the immunosuppressive function of macrophages, shifted regulatory T cells (T regs ) to T H 17 cells, and increased the number and activity of tumor-infiltrating T effectors, thereby enhancing antitumor efficacy in synergy with immune checkpoint blockade therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsTumor-Associated MacrophagesImmunotherapySphingolipidsLysophospholipidsDrug Resistance, NeoplasmHumansTumor MicroenvironmentAnimalsSphingosineMiceNIMA-Related KinasesCell Line, TumorMaleT-Lymphocytes, Regulatory

Substanzen

Sphingolipidssphingosine 1-phosphateSphingosineLysophospholipidsNIMA-Related Kinases

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China.
  • Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, Zhejiang, China.
  • MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China.
  • Department of Breast, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China.
  • Department of Oncology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China.

ORCID-Profile: Xiaozhen Zhang, Mengyi Lao, Hanshen Yang, Lihong He, Xiaoyu Zhang, Xiongbin Lu, Xueli Bai, Tingbo Liang

Zitieren

APA

Zhang, X., Lao, M., Sun, K., Yang, H., He, L., Liu, X., Liu, L., Zhang, S., Guo, C., Wang, S., Shi, J., Zhang, X., Xu, D., Lu, X., Bai, X., & Liang, T. (2025). Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma. Science Advances, 11(21). https://doi.org/10.1126/sciadv.adv0558

Vancouver

Zhang X, Lao M, Sun K, Yang H, He L, Liu X, et al. Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma. Science Advances. 2025;11(21). doi:10.1126/sciadv.adv0558

BibTeX
@article{Zhang2025,
  author = {Zhang, Xiaozhen and Lao, Mengyi and Sun, Kang and Yang, Hanshen and He, Lihong and Liu, Xinyuan and Liu, Linyue and Zhang, Sirui and Guo, Chengxiang and Wang, Sicheng and Shi, Jiatao and Zhang, Xiaoyu and Xu, Daqian and Lu, Xiongbin and Bai, Xueli and Liang, Tingbo},
  title = {Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {21},
  doi = {10.1126/sciadv.adv0558}
}
Kostenlos starten →